Key result
Physician-pharmacist collaboration sustains ~75% higher BP control nine months after discontinuation versus standard care.
Why the study?
Does a physician-pharmacist collaborative intervention maintain improved blood pressure control after discontinuation in patients with hypertension?
RCT (n=104)
cluster-randomized
Yes
Does a physician-pharmacist collaborative intervention maintain improved blood pressure control after discontinuation in patients with hypertension?
A physician-pharmacist collaborative intervention provides sustained benefits on blood pressure control up to 18 months after discontinuation, though control rates gradually deteriorate, suggesting the need for ongoing pharmacist involvement.
Answers are grounded in this paper and cite their sources.
Sustained BP control benefit seen 18 months post-intervention; leaves open whether ongoing pharmacist involvement is needed to prevent deterioration.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Carter et al. (2010) conducted an RCT in hypertension (n=104). physician-pharmacist collaborative intervention vs. control group was evaluated on blood pressure control at 18 months (9 months post-discontinuation) (p=0.02). After discontinuation of a physician-pharmacist collaborative intervention, blood pressure control remained significantly higher in the intervention group at 18 months (53.9% vs 30.8%, p=0.02).
Synapse has enriched 10 related papers. Consider them for comparative context: